NELL-1 in the treatment of osteoporotic bone loss
- Univ. of California, Los Angeles, CA (United States)
- Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States)
- Colorado State Univ., Fort Collins, CO (United States)
NELL-1 is a secreted, osteoinductive protein whose expression rheostatically controls skeletal ossification. Overexpression of NELL-1 results in craniosynostosis in humans and mice, whereas lack of Nell-1 expression is associated with skeletal undermineralization. Here we show that Nell-1-haploinsufficient mice have normal skeletal development but undergo age-related osteoporosis, characterized by a reduction in osteoblast: osteoclast (OB:OC) ratio and increased bone fragility. Recombinant NELL-1 binds to integrin β1 and consequently induces Wnt/β-catenin signalling, associated with increased OB differentiation and inhibition of OC-directed bone resorption. Systemic delivery of NELL-1 to mice with gonadectomy-induced osteoporosis results in improved bone mineral density. When extended to a large animal model, local delivery of NELL-1 to osteoporotic sheep spine leads to significant increase in bone formation. Furthermore, these findings suggest that NELL-1 deficiency plays a role in osteoporosis and demonstrate the potential utility of NELL-1 as a combination anabolic/antiosteoclastic therapeutic for bone loss.
- Research Organization:
- Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)
- Sponsoring Organization:
- USDOE
- Grant/Contract Number:
- AC05-00OR22725
- OSTI ID:
- 1333652
- Journal Information:
- Nature Communications, Journal Name: Nature Communications Vol. 6; ISSN 2041-1723
- Publisher:
- Nature Publishing GroupCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Leonurine hydrochloride promotes osteogenic differentiation and increases osteoblastic bone formation in ovariectomized mice by Wnt/β-catenin pathway
Prostaglandin E2 Signals Through PTGER2 to Regulate Sclerostin Expression
Human stem cell osteoblastogenesis mediated by novel glycogen synthase kinase 3 inhibitors induces bone formation and a unique bone turnover biomarker profile in rats
Journal Article
·
Mon Oct 15 00:00:00 EDT 2018
· Biochemical and Biophysical Research Communications
·
OSTI ID:23107865
Prostaglandin E2 Signals Through PTGER2 to Regulate Sclerostin Expression
Journal Article
·
Tue Mar 15 20:00:00 EDT 2011
· PLoS ONE
·
OSTI ID:1627449
Human stem cell osteoblastogenesis mediated by novel glycogen synthase kinase 3 inhibitors induces bone formation and a unique bone turnover biomarker profile in rats
Journal Article
·
Tue Oct 15 00:00:00 EDT 2013
· Toxicology and Applied Pharmacology
·
OSTI ID:22285432